Structure of the D2 dopamine receptor bound to the atypical antipsychotic drug risperidone

Nature
Sheng WangBryan L Roth

Abstract

Dopamine is a neurotransmitter that has been implicated in processes as diverse as reward, addiction, control of coordinated movement, metabolism and hormonal secretion. Correspondingly, dysregulation of the dopaminergic system has been implicated in diseases such as schizophrenia, Parkinson's disease, depression, attention deficit hyperactivity disorder, and nausea and vomiting. The actions of dopamine are mediated by a family of five G-protein-coupled receptors. The D2 dopamine receptor (DRD2) is the primary target for both typical and atypical antipsychotic drugs, and for drugs used to treat Parkinson's disease. Unfortunately, many drugs that target DRD2 cause serious and potentially life-threatening side effects due to promiscuous activities against related receptors. Accordingly, a molecular understanding of the structure and function of DRD2 could provide a template for the design of safer and more effective medications. Here we report the crystal structure of DRD2 in complex with the widely prescribed atypical antipsychotic drug risperidone. The DRD2-risperidone structure reveals an unexpected mode of antipsychotic drug binding to dopamine receptors, and highlights structural determinants that are essential for the actio...Continue Reading

References

Feb 11, 1992·Trends in Pharmacological Sciences·D R Sibley, F J Monsma
Dec 1, 1989·Proceedings of the National Academy of Sciences of the United States of America·D K GrandyA C Server
Dec 22, 1988·Nature·J R BunzowO Civelli
Feb 11, 1998·Physiological Reviews·C MissaleM G Caron
Jul 24, 1998·Biophysical Journal·K Gallagher, K Sharp
Aug 5, 2000·Science·K PalczewskiM Miyano
Apr 3, 2004·Nature Reviews. Drug Discovery·Bryan L RothWesley K Kroeze
Mar 1, 2005·British Journal of Pharmacology·David J Roberts, Philip G Strange
Jul 21, 2006·Acta Crystallographica. Section D, Biological Crystallography·Wladek MinorMaksymilian Chruszcz
Jan 5, 2007·The New England Journal of Medicine·Bryan L Roth
Nov 14, 2007·Archives of Neurology·Nora D VolkowFrank Telang
Apr 25, 2009·Nature Protocols·Martin Caffrey, Vadim Cherezov
Aug 1, 2007·Journal of Applied Crystallography·Airlie J McCoyRandy J Read
Feb 4, 2010·Acta Crystallographica. Section D, Biological Crystallography·Paul D AdamsPeter H Zwart
Apr 13, 2010·Acta Crystallographica. Section D, Biological Crystallography·P EmsleyK Cowtan
Aug 26, 2010·Journal of Chemical Information and Modeling·Michael M Mysinger, Brian K Shoichet
Feb 10, 2011·Pharmacological Reviews·Jean-Martin Beaulieu, Raul R Gainetdinov
Jul 21, 2011·Nature·Søren G F RasmussenBrian K Kobilka
Oct 26, 2011·Proceedings of the National Academy of Sciences of the United States of America·John A AllenJian Jin
Jun 22, 2012·Journal of Medicinal Chemistry·Michael M MysingerBrian K Shoichet
Oct 8, 2013·PloS One·Ryan G ColemanBrian K Shoichet
Sep 10, 2014·Current Protocols in Bioinformatics·Benjamin Webb, Andrej Sali
Aug 18, 2016·Nature·Aashish ManglikBrian K Shoichet
Jul 29, 2017·Cell·Daniel WackerBryan L Roth
Dec 12, 2017·Nature Chemical Biology·John D McCorvyBryan L Roth

❮ Previous
Next ❯

Citations

Aug 4, 2018·The British Journal of Psychiatry : the Journal of Mental Science·Derek K TracySukhwinder S Shergill
Sep 6, 2018·Molecules : a Journal of Synthetic Chemistry and Natural Product Chemistry·Magda KondejAgnieszka A Kaczor
Jun 5, 2019·Molecules : a Journal of Synthetic Chemistry and Natural Product Chemistry·Ambrose PlanteHarel Weinstein
Jul 2, 2019·Physical Chemistry Chemical Physics : PCCP·Jose E M PereiraHeloisa N Bordallo
Jun 21, 2018·The Journal of Pharmacology and Experimental Therapeutics·Richard M KostrzewaRaul R Gainetdinov
Sep 13, 2019·Critical Reviews in Microbiology·Yiliang WangYifei Wang
Sep 1, 2019·International Journal of Psychiatry in Medicine·Paul A Zarkowski
Feb 14, 2020·FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology·Agnieszka KotarskaMelitta Schachner
Mar 9, 2018·Nature·David R Sibley, Lei Shi
Mar 27, 2020·Molecules : a Journal of Synthetic Chemistry and Natural Product Chemistry·Igor SieradzkiSabina Podlewska
Jun 9, 2020·Journal of Computational Chemistry·Rodrigo D TossoRicardo D Enriz
Feb 7, 2019·Nature Structural & Molecular Biology·Kanako Terakado KimuraTatsuro Shimamura
Mar 6, 2019·Frontiers in Endocrinology·Diego GuidolinLuigi F Agnati
Aug 30, 2019·International Journal of Molecular Sciences·Alexander I KostyukDmitry S Bilan
Nov 5, 2019·The Journal of Biological Chemistry·María E Terrón-DíazTheodore G Wensel
Sep 26, 2019·Current Topics in Medicinal Chemistry·Daniel E FelsingJohn A Allen
Mar 4, 2020·Nature Communications·Tao CheBryan L Roth
Aug 9, 2020·Frontiers in Pharmacology·Jean Claude Martel, Silvia Gatti McArthur
Sep 15, 2018·Frontiers in Pharmacology·Dasiel O Borroto-EscuelaJens Carlsson
Aug 19, 2018·Molecular Psychiatry·Prashant DonthamsettiJonathan A Javitch
Aug 23, 2018·Scientific Reports·Annika FrankHolger Stark
Nov 30, 2018·Molecular Diversity·Stanisław JastrzębskiSabina Podlewska
Sep 22, 2019·International Journal of Molecular Sciences·Agata ZiębaAgnieszka A Kaczor
Apr 17, 2019·International Journal of Molecular Sciences·Elise WoutersChristophe Stove
Mar 1, 2018·Nature·David R Sibley, Lei Shi
Dec 21, 2019·Nature Communications·Serap ErdogmusMichael Mederos Y Schnitzler

❮ Previous
Next ❯

Methods Mentioned

BETA
Assay
PCR
X-ray

Software Mentioned

OpenEye
DUD
AMBER
PHENIX
PHASER
AMSOL
DELPHI
REFMAC
PROMALS3D
QNIFFT

Related Concepts

Related Feeds

Antipsychotic Drugs

Antipsychotic drugs are a class of medication primarily used to manage psychosis (including delusions, hallucinations, paranoia or disordered thought), principally in schizophrenia and bipolar disorder. Discover the latest research on antipsychotic drugs here

Attention Disorders

Attention is involved in all cognitive activities, and attention disorders are reported in patients with various neurological diseases. Here are the latest discoveries pertaining to attention disorders.

Addiction

This feed focuses mechanisms underlying addiction and addictive behaviour including heroin and opium dependence, alcohol intoxication, gambling, and tobacco addiction.